Lv2
130 积分 2024-04-09 加入
MM-711: Safety Outcomes Following Frontline Daratumumab-Based Therapy in Multiple Myeloma: A Systematic Reviewand Meta-Analysis
6天前
已关闭
A randomized, double-blind, single-dose, parallel two-group study comparing the pharmacokinetics, safety, and immunogenicity of BAT1806 SC with tocilizumab in healthy Chinese male subjects
24天前
已完结
Bevacizumab: A Review of Its Use in Advanced Cancer
1个月前
已完结
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
1个月前
已完结
First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis
1个月前
已完结
An Open-Label Clinical Trial Evaluating Safety and Pharmacokinetics of Two Dosing Schedules of Panitumumab in Patients with Solid Tumors
1个月前
已完结
A Phase 1 Bioequivalence Study to Assess the Pharmacokinetics, Safety and Tolerability of Guselkumab After a Single‐Dose Administration via Two Subcutaneous Injection Devices in Healthy Volunteers
1个月前
已完结
Population Pharmacokinetic Modeling of Guselkumab, a Human IgG1λ Monoclonal Antibody Targeting IL‐23, in Patients with Moderate to Severe Plaque Psoriasis
1个月前
已完结
Population Pharmacokinetic Analysis of Panitumumab in Patients With Advanced Solid Tumors
3个月前
已完结
Experimental, extrapolated and truncated areas under the concentration-time curve in bioequivalence trials
4个月前
已完结
皖公网安备34019202002308
